A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial

EWER K., FOLEGATTI P., BITTAYE M., HILL A., FLAXMAN A., BELLAMY D., MAKINSON R.

Type

Journal article

Publisher

Nature Research (part of Springer Nature)

Publication Date

2021-07-12T00:00:00+00:00

Permalink Close